1.
Journal of the Korean Neurological Association
;
: 176-180, 2022.
Article
in Korean
| WPRIM
| ID: wpr-926296
ABSTRACT
Monoclonal antibodies are pure antibodies that react to a specific epitope. Plasmapheresis is a treatment that separates and eliminates disease-causing substances before replacing the blood with plasma. Plasmapheresis has insufficient evidence for treating new-onset refractory status epilepticus (NORSE). Sequential plasmaphereses gradually improved a female cryptogenic NORSE patient who did not benefit from monoclonal antibody treatment.